China is a very rapidly changing market for medicines. My understanding is pricing is around 1/3rd the USA, but the market is considerably larger. Just like the USA there is an issue around insurance coverage for the poorest people, but there is a very large pool of people who can afford the cost of something like RC220 bisantrene.
Overall it is an open question of which market is the most important for RC220 - USA or China.
General Comments / Chat, page-11605
-
- There are more pages in this discussion • 408 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
